Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 855.46 Million EUR | -10.91% |
| 2022 | 960.26 Million EUR | 2.4% |
| 2021 | 937.77 Million EUR | 3.07% |
| 2020 | 909.85 Million EUR | 9.71% |
| 2019 | 829.33 Million EUR | -30.29% |
| 2018 | 1.18 Billion EUR | 1.81% |
| 2017 | 1.16 Billion EUR | -23.48% |
| 2016 | 1.52 Billion EUR | -4.01% |
| 2015 | 1.59 Billion EUR | -0.44% |
| 2014 | 1.59 Billion EUR | 9.02% |
| 2013 | 1.46 Billion EUR | -1.72% |
| 2012 | 1.49 Billion EUR | 1.05% |
| 2011 | 1.47 Billion EUR | 0.06% |
| 2010 | 1.47 Billion EUR | 6.07% |
| 2009 | 1.39 Billion EUR | -23.48% |
| 2008 | 1.81 Billion EUR | 2.56% |
| 2007 | 1.77 Billion EUR | -2.29% |
| 2006 | 1.81 Billion EUR | -1.74% |
| 2005 | 1.84 Billion EUR | 15.06% |
| 2004 | 1.6 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 855.71 Million EUR | 0.0% |
| 2024 Q1 | 855.71 Million EUR | 0.03% |
| 2023 Q4 | 855.46 Million EUR | 0.0% |
| 2023 Q1 | 912.92 Million EUR | -4.93% |
| 2023 Q3 | 855.46 Million EUR | -6.29% |
| 2023 Q2 | 912.92 Million EUR | 0.0% |
| 2023 FY | 855.46 Million EUR | -10.91% |
| 2022 Q3 | 960.26 Million EUR | -3.94% |
| 2022 Q4 | 960.26 Million EUR | 0.0% |
| 2022 FY | 960.26 Million EUR | 2.4% |
| 2022 Q1 | 999.63 Million EUR | 6.6% |
| 2022 Q2 | 999.63 Million EUR | 0.0% |
| 2021 Q2 | 939.02 Million EUR | 0.0% |
| 2021 Q3 | 937.77 Million EUR | -0.13% |
| 2021 Q1 | 939.02 Million EUR | 3.21% |
| 2021 Q4 | 937.77 Million EUR | 0.0% |
| 2021 FY | 937.77 Million EUR | 3.07% |
| 2020 Q1 | 986.52 Million EUR | 18.95% |
| 2020 Q3 | 909.85 Million EUR | -7.77% |
| 2020 Q2 | 986.52 Million EUR | 0.0% |
| 2020 FY | 909.85 Million EUR | 9.71% |
| 2020 Q4 | 909.85 Million EUR | 0.0% |
| 2019 Q1 | 925.31 Million EUR | -22.22% |
| 2019 Q3 | 829.33 Million EUR | -10.37% |
| 2019 Q2 | 925.31 Million EUR | 0.0% |
| 2019 FY | 829.33 Million EUR | -30.29% |
| 2019 Q4 | 829.33 Million EUR | 0.0% |
| 2018 Q3 | 1.18 Billion EUR | 0.02% |
| 2018 Q1 | 1.18 Billion EUR | 1.79% |
| 2018 FY | 1.18 Billion EUR | 1.81% |
| 2018 Q4 | 1.18 Billion EUR | 0.0% |
| 2018 Q2 | 1.18 Billion EUR | 0.0% |
| 2017 Q2 | 1.46 Billion EUR | 0.0% |
| 2017 Q1 | 1.46 Billion EUR | -3.82% |
| 2017 FY | 1.16 Billion EUR | -23.48% |
| 2017 Q4 | 1.16 Billion EUR | 0.0% |
| 2017 Q3 | 1.16 Billion EUR | -20.44% |
| 2016 Q1 | 1.6 Billion EUR | 1.09% |
| 2016 FY | 1.52 Billion EUR | -4.01% |
| 2016 Q4 | 1.52 Billion EUR | 0.0% |
| 2016 Q3 | 1.52 Billion EUR | -5.04% |
| 2016 Q2 | 1.6 Billion EUR | 0.0% |
| 2015 Q3 | 1.59 Billion EUR | -3.36% |
| 2015 Q4 | 1.59 Billion EUR | -0.56% |
| 2015 Q2 | 1.65 Billion EUR | -2.66% |
| 2015 FY | 1.59 Billion EUR | -0.44% |
| 2015 Q1 | 1.7 Billion EUR | 6.43% |
| 2014 Q3 | 1.57 Billion EUR | 2.87% |
| 2014 Q4 | 1.59 Billion EUR | 1.21% |
| 2014 Q1 | 1.49 Billion EUR | 1.89% |
| 2014 FY | 1.59 Billion EUR | 9.02% |
| 2014 Q2 | 1.53 Billion EUR | 2.77% |
| 2013 Q4 | 1.46 Billion EUR | 1.93% |
| 2013 FY | 1.46 Billion EUR | -1.72% |
| 2013 Q3 | 1.43 Billion EUR | -3.11% |
| 2013 Q2 | 1.48 Billion EUR | -2.64% |
| 2013 Q1 | 1.52 Billion EUR | 2.2% |
| 2012 Q2 | 1.55 Billion EUR | 5.38% |
| 2012 Q4 | 1.49 Billion EUR | 1.05% |
| 2012 FY | 1.49 Billion EUR | 1.05% |
| 2012 Q1 | 1.47 Billion EUR | -0.19% |
| 2012 Q3 | 1.47 Billion EUR | -4.92% |
| 2011 FY | 1.47 Billion EUR | 0.06% |
| 2011 Q1 | 1.44 Billion EUR | -2.29% |
| 2011 Q2 | 1.44 Billion EUR | 0.01% |
| 2011 Q3 | 1.45 Billion EUR | 0.91% |
| 2011 Q4 | 1.47 Billion EUR | 1.46% |
| 2010 FY | 1.47 Billion EUR | 6.07% |
| 2010 Q1 | 1.48 Billion EUR | 6.95% |
| 2010 Q2 | 1.56 Billion EUR | 5.19% |
| 2010 Q4 | 1.47 Billion EUR | 2.31% |
| 2010 Q3 | 1.44 Billion EUR | -7.84% |
| 2009 Q4 | 1.39 Billion EUR | 0.0% |
| 2009 FY | 1.39 Billion EUR | -23.48% |
| 2008 FY | 1.81 Billion EUR | 2.56% |
| 2007 FY | 1.77 Billion EUR | -2.29% |
| 2006 FY | 1.81 Billion EUR | -1.74% |
| 2005 FY | 1.84 Billion EUR | 15.06% |
| 2004 FY | 1.6 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -46441.571% |
| Ansell Limited | 3.23 Billion USD | 73.569% |
| Ansell Limited | 3.24 Billion USD | 73.618% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -74.945% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -284710.329% |
| Psykey, Inc. | 1.72 Million USD | -49424.245% |
| ConvaTec Group Plc | 3.7 Billion USD | 76.932% |
| ConvaTec Group Plc | 3.71 Billion USD | 76.965% |
| Encision Inc. | 3.81 Million USD | -22348.852% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -131129.78% |
| LifePoint, Inc. | 8.8 Million USD | -9611.039% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -5261.381% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -95482.346% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -15484.903% |
| Reflect Scientific, Inc. | 2.66 Million USD | -31952.945% |
| SmileDirectClub, Inc. | 597.06 Million USD | -43.278% |
| Sector 10, Inc. | 1000.00 USD | -85546100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 81.976% |
| SheerVision, Inc. | 837.56 Thousand USD | -102036.789% |
| United Health Products, Inc. | 284.64 Thousand USD | -300438.569% |
| Vasamed, Inc. | 1.6 Million USD | -53358.256% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -383217.874% |
| Yubo International Biotech Limited | 2.34 Million USD | -36325.098% |